0001203311-23-000016.txt : 20230221
0001203311-23-000016.hdr.sgml : 20230221
20230221193335
ACCESSION NUMBER: 0001203311-23-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIU JEAN I
CENTRAL INDEX KEY: 0001241357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23650110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2023-02-16
0
0001060736
Seagen Inc.
SGEN
0001241357
LIU JEAN I
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Legal Officer
Common Stock
2023-02-16
4
M
0
5000
39.15
A
90113
D
Common Stock
2023-02-16
4
S
0
5000
155.0
D
85113
D
Non-Qualified Stock Option (right to buy)
39.15
2023-02-16
4
M
0
5000
0.0
D
2025-08-25
Common Stock
5000
17446
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all the options were fully vested on 8/25/19.
By: /s/ Jennifer Prosba For: Jean I Liu
2023-02-21